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Abstract
Demographic change, new health threats and inequalities in health and healthcare provision in and between 
European Union (EU) member states pose a great challenge to European health care systems. Not only for these 
reasons does it make sense to collect comparable European health data. Such information provides insights on 
the distribution of risk and protection factors, the prevalence of chronic diseases and the levels of care provided in 
the member states and supports the planning and implementation of (health) policy measures. Since 2013, in the 
context of the European Health Interview Survey (EHIS), all EU member states are obliged to collect data on the 
health status, the provision of healthcare, health determinants and socio-economic conditions of their populations. 
In Germany, the EHIS is integrated into health monitoring at the Robert Koch Institute (RKI). The RKI is thus 
Germany’s interface to the European health monitoring presented here. European health monitoring relies on 
different indicator systems such as the European Core Health Indicators (ECHI), EU social indicators and the health 
indicators of the European Sustainable Development Strategy. These are based on administrative and survey data, 
which stem for example from the EHIS or the European Union Statistics on Income and Living Conditions (EU-SILC) 
survey. Comparative data analyses must take into account the differences between health care systems, socio-
economic conditions and the age structures of societies. Variances in the prevalence of allergies for example are 
also due to differences in the available diagnostic tools. Significant differences in the prevalence of hypertension 
in Europe (with a range of 20% for women and 17% for men) are also related to different levels of awareness of 
hypertension. Comparative analyses can support the planning of and provide information for policy measures, and 
enhance the sharing of experiences between EU member states. A forthcoming EU regulation aims to harmonise 
the content of and intervals between health and social statistical data collection. Moreover, plans exist to establish 
a European Research Infrastructure Consortium (ERIC), which is set to develop and institutionalise European health 
monitoring.
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1.  Background 
‘Health’ has gradually developed as a European policy 
field. During the 1950s, the predecessor to the Europe-
an Commission provided support to member states in 
the field of occupational health and safety for coal and 
steel industry workers. Today, European health policy 
covers fields such as disease prevention and control, 
provision of medicines and health research. Yet, for Euro-
pean citizens, the main responsibility for health policy 
and health care still remains at member state level. The 
EU supports, coordinates or supplements measures that 
are adopted by the member states (article 6 of the Trea-
ty on the Functioning of the European Union, TFEU) [1]. 
Article 168 TFEU defines the framework and goals of this 
supplementing competency of the EU and emphasises 
the importance of health for all EU policy fields (see Info 
box 1).
To complement this, and in the face of current chal-
lenges to health care systems – demographic change, 
migration, the financial crisis, new health threats (such 
as pandemics, bio-terrorism and climate change) and 
advances in medical technologies – the EU developed 
its health strategy ‘Together for Health’. The strategy 
complements the Europe 2020 strategy and its focus on 
increasing productivity and competitiveness in the EU. 
Within this context, investments into health care are to 
help reduce health inequalities and combat social exclu-
sion. Overarching values such as universality, access to 
good quality care, equity and solidarity are to guide the 
systems for the provision of healthcare in the EU and 
take into account the gender perspective [3]. 
Info box 1: Treaty on the Functioning 
of the European Union, 
article 168 (Public Health) 
“1. A high level of human health protection 
shall be ensured in the definition and 
implementation of all Union policies and 
activities. Union action, which shall com-
plement national policies, shall be direct-
ed towards improving public health, pre-
venting physical and mental illness and 
diseases, and obviating sources of danger 
to physical and mental health. Such action 
shall cover the fight against the major 
health scourges by promoting research 
into their causes, their transmission and 
their prevention as well as health infor-
mation and education, and monitoring, 
early warning of and combating serious 
cross-border threats to health. […]
2. The Union shall encourage cooperation 
between the Member States in the areas 
referred to in this Article and, if necessary, 
lend support to their action. […]
3. The Union and the Member States shall 
foster cooperation with third countries 
and the competent international organi-
sations in the sphere of public health. […]
7. Union action shall respect the responsi-
bilities of the Member States for the defi-
nition of their health policy and for the 
organisation and delivery of health servic-
es and medical care [2].“ 
For European health care systems to react adequately 
to the above-mentioned challenges and develop strate-
gies to improve health will require regular data on the 
development of living conditions, health status and 
behaviour, and healthcare levels in Europe. The Euro-
pean statistics office (Eurostat), the Organisation for 
Economic Co-operation and Development (OECD) and 
the World Health Organisation (WHO regional office for 
Europe) all provide and publish data on health in Europe 
at regular intervals. Every two years, the OECD, in coop-
eration with the European Commission, publishes its 
Health at a Glance report [4] and every three years the 
WHO’s regional office for Europe publishes its European 
health report [5].
Indicators that aim for the greatest comparability 
between countries and allow for quantified assessments 
of the health status, health behaviour and determinants 
for health and well-being are the basis of these reports. In 
the following, this article focuses on EU indicator systems 
and their sources of data. As an example, it provides com-
parative analyses for selected chronic diseases from the 
second wave of the European Health Interview Survey 
(EHIS-2). To conclude, the article discusses the perspec-
tives and limitations of European health monitoring.
2. EU health indicator (systems)
As standardised measures, indicators can help reveal pro-
cesses, results or changes at a certain moment in time or 
over a period of time [6-8]. Standardised data collection 
on the basis of European health indicators is of fundamen-
tal importance for the development of national and Euro-
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pean research and health policies [9]. This helps identify 
and close gaps in the data and contributes towards data-
based objectivity and scientific orientation of health policy 
discussions. EU indicator systems relevant to health 
include the European Core Health Indicators (ECHI), Euro-
pean social indicators and the public health indicators of 
the European Sustainable Development Strategy, which 
are described in more detail below. Numerous links exist 
between these systems and with sets of indicators on spe-
cific topics such as accidents or child and youth health. 
2.1  European Core Health Indicators (ECHI) 
At the end of the 1990s, the EU decided to establish 
“Community Health Indicators” [10]. Between 1998 and 
2012, four projects (ECHI-1, ECHI-2, ECHIM, JA ECHIM) 
led to the development of the ECHI shortlist with 88 
indicators (European Core Health Indicators). ECHI indi-
cators rely on a large number of data sources. To ensure 
the comparability of data, each indicator has a defined 
preferred data source (such as Eurostat) and a preferred 
type of data (such as survey data) [11]. Section 3 (“Data 
sources for EU health indicators”) describes a number 
of data sources for EU health indicators in detail. Data 
collected on the basis of the ECHI indicators can be 
accessed, downloaded or visualised in aggregated form 
on the EU’s publicly accessible ECHI Data Tool [12].
The declared aim was not to select indicators based 
solely on data availability [13]. Correspondingly, the ECHI 
shortlist is divided into three sections that reflect the 
different degrees of implementation readiness of spe-
cific indicators. Data from defined international data 
sources from the preferred type of data is available for 
67 indicators (implementation section). A further 14 indi-
cators (work-in-progress section) have been sufficiently 
developed both at the conceptual and methodological 
level, yet final obstacles to their Europe-wide implemen-
tation remain. The third group (development section) 
comprises topics of issues that, although relevant to 
health policy, still require discussion before they can be 
developed conceptually and methodologically into indi-
cators [11]. The inclusion of new indicators or the trans-
fer of indicators between sections is based on consen-
sually decided criteria. Documentation forms are 
available for all indicators and structured remarks on 
their comparability are provided for most of them. The 
majority of implemented indicators can be stratified 
according to age, gender, education and region where 
this is considered useful. 
The implementation of indicators in the health infor-
mation systems of member states began in 2005. Numer-
ous EU countries have already implemented ECHI indica-
tors in national health monitoring. Federal health reporting 
data in Germany is also provided according to the defini-
tions in the ECHI shortlist. 
The further development of the ECHI shortlist is part 
of the EU-funded BRIDGE health project (BRidging Infor-
mation and Data Generation for Evidence-based health 
policy and research). Generally, the goal is to keep the list 
of indicators as stable as possible. For different reasons, 
however, it may become necessary to update indicators. 
Such reasons include changes to EU health surveys, new 
relevant public health concerns or changes to health pol-
icy concepts. A good example here are shifts in the con-
Comparable health data  
is needed to support the  
planning and implementation 
of health policy measures  
in Europe.
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ceptual approaches toward disability. Whereas in the past 
questions used to focus on a person’s disabilities, they 
today ask about the barriers people with disabilities face 
for their full participation in society [14]. Figure 1 illustrates 
the policy fields, sections and data of ECHI indicators. 
Cancer incidence, self-reported prevalence of asthma, 
diabetes, depression and chronic obstructive pulmonary 
disease (COPD) are all among the non-communicable 
diseases ECHI indicators currently monitor. Indicators 






Age (available for 60 indicators) 
Gender (available for 54 indicators) 
Education (available for 43 indicators) 
Region (ISARE; available for 43 indicators)
Chapter: 
Demography and socio-economic situation 
Health status 




Health care provision 
Ageing and population 
Health determinants 
Diseases and mental health 
Health in all policy fields
Data sets: 
International and European disease registries 
 EU and European institutions (Eurostat, research and  
surveillance agencies, foundations, databases, consortia) 
Databases of international organisations (OECD, UN, WHO)
Data types: 
Administrative and registry data 
Population data 




National and European level health monitoring
ECHI shortlist
EU=European Union; OECD= Organisation for Economic Co-operation and Development; UN=United Nations; WHO=World Health Organisation;  
ISARE=Indicateurs de Santé dans les Régions d’Europe; Eurostat=Statistical Office of the European Union
Fig. 1 
ECHI shortlist structure, data sets, application 
Source: own chart based on [16, 17]
The key European indicator 
systems are the European 
Core Health Indicators 
(ECHI), EU social indicators 
and the health indicators of 
the European Sustainable 
Development Strategy.
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ter-based prevalences of asthma, COPD, diabetes, 
dementia and depression are still under development. 
Cause of death statistics are a further source of informa-
tion on disease in Europe. The corresponding indicator 
in the ECHI shortlist (indicator 13) includes 26 ICD-10 
causes of death. Cause of death statistics, however, offer 
no information on disease incidence and prevalence. 
Future Europe-wide diagnosis-specific morbidity statis-
tics should close this gap also in the data on chronic 
disease. Eurostat in collaboration with EU member 
states is currently conducting corresponding pilot stud-
ies [15]. 
Info box 2: EU social indicators 
EU social indicators are an instrument that 
was developed in the context of the strategy 
to promote growth, a dynamic economy and 
social cohesion in the EU (the Lisbon Strat-
egy), adopted by the European Council in 
2000. In social policy, the EU has shared 
competence and coordinating capacity (arti-
cles 4 and 5 TFEU) [1]. To implement the 
goals of the Lisbon Strategy, Europe devel-
oped the open method of coordination 
(OMC). The method was ‘launched […] as 
voluntary self-evaluating process, based on 
common objectives, [...]’ [18]. In the area of 
health, social indicators are to allow for 
self-evaluation, comparison and benchmark-
ing in healthcare and long-term care provi-
sion. Since 2005, social indicators have been 
the basis for the European Survey on Income 
and Living Conditions, EU-SILC. It compris-
es the Minimum European Health Module 
(MEHM), consisting of seven variables [19]. 
Indicator topics relevant to health: 
 Access to health care services 
 Quality of healthcare 
 Sustainable healthcare systems (expenditure/efficiency) 
 Medical staff, healthcare expenditure (context indicators)
 
Policy fields: 
 Europe 2020 target to reduce poverty and social exclusion 
 Social integration 
 Pensions 
 Healthcare and longterm care 
 Overarching indicators
Main sources of data: 
 EU Statistics on Income and Living Conditions (EU-SILC) 
 EU Labour Force Survey (EU-LFS)
     
Application: 
Europe 2020 target to reduce poverty and social exclusion 
Country-specific social problems/trends (European 
Semester, the Joint Assessment Framework, the Social 
Protection Performance Monitor)  
EU country social reports 
Social Protection Committee Annual Report 
Analyses and reports at EU level (such as on pensions in 
the EU, or on child poverty)
EU social indicators
EU=European Union 
2.2  EU social indicators relevant to health
In addition to the Core Health Indicators, the system of 
EU social indicators also reflects questions relevant to 
health. They are embedded in the context of EU social 
policy and focus on healthcare provision and long-term 
care (see Info box 2; Figure 2).
In 2010, the Europe 2020 strategy succeeded the Lis-
bon Strategy and provided a greater focus on questions 
of health in Europe. The 2013 EU Annual Growth Survey 
emphasised the need to analyse how the healthcare sys-
tems of member states can manage the twofold challenge 
Fig. 2 
EU social indicators, health issues, 
data sources, application 
Source: own chart based on [20]
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of ensuring access to high quality healthcare services 
whilst keeping the costs at manageable levels in the long 
term [18, 21]. Moreover, the strategy in particular recog-
nised the need to reduce inequalities between member 
states, regions and socio-economic groups [22]. Adjusted 
indicators to reflect this fact are being developed at EU 
level with the participation of member states. These efforts 
are based on the Joint Assessment Framework (JAF) 
method [23]. JAF health indicators aim to enhance the 
evidence basis of EU health policy activities and recom-
mendations to member states [24]. The set of indicators 
currently being developed includes EU social indicators 
and indicators from the ECHI shortlist. Among these are 
outcome indicators such as life expectancy, healthy life 
years, self-perceived health, infant mortality and causes 
of death. Further indicators shed light on the accessibility 
and quality of healthcare services such as unmet health-
care needs, vaccination coverage, screening, avoidable 
hospital admissions as well as on health determinants 
(tobacco and alcohol consumption, physical activity, obe-
sity, and fruit and vegetable consumption). Additional 
(called contextual) indicators provide information on 
healthcare expenditure as well as on sociodemographic 
factors [25]. The set of indicators differentiates between 
EU indicators, national (NAT) indicators as well as con-
textual indicators. Only EU indicators are applicable for 
comparisons between member states.
2.3  Sustainability indicators
In 2001, the European Council adopted the EU Sustaina-
ble Development Strategy, which was renewed in 2006. 
Public health is one of the ten issues the EU has identified 
as key challenges to sustainable development and for 
which it states targets, operational objectives and actions. 
Progress is measured based on around 130 indicators [26]. 
Focuses for the complex of public health are the pro-
motion of good public health on equal conditions for all 
citizens and improved protection against health threats. 
Indicators such as life expectancy, healthy life years and 
chronic disease mortality rates are important as is data 
on the production of toxic chemicals, air or noise pollu-
tion and accidents at work. Further indicators include 
unmet healthcare needs, long-term illness or health con-
ditions [27]. The sustainability indicators are also based 
on administrative health data as well as on data from 
social and economic monitoring. Every two years, a mon-
itoring report is published; the most recent one was pub-
lished in September 2015 [28]. 
Some are stand-alone health surveys, whilst others 
contain health-related modules or variables within a 
larger overarching complex of issues. Table 1 presents 
an overview of European health surveys and indicators. 
The following section then focuses on the most impor-
tant data sources for health indicators.
3.  Data sources for EU health indicators 
Data availability is addressed early in the process of 
conceptualizing and developing European and interna-
tional sets of indicators. This ensures that meaningful 
and comparable data will be available for all countries 
involved. Individual indicators are taken from different 
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Focus Health indicators
EHIS  
(European health interview survey)*
Health Demography and socioeconomic situation, 
health status, health determinants and measures 
by the healthcare system
EU-SILC  
(EU statistics on income and living  
conditions)*
Income and living conditions Health status and utilisation of the healthcare system 
(minimum European health module: MEHM, 
seven variables)
EU LFS  
(EU Labour Force Survey)* 
Labour market conditions and 
trends
Employment of disabled people (2002, 2011); 
accidents at work and other work-related health 
problems (1999, 2007, 2013) (ad-hoc modules)
OECD/Eurostat/WHO in the System  
of Health Accounts (SHA)
Health expenditure Including costs of investments in the health sector, 
income from programmes to finance healthcare, 
contributions to cover the costs of healthcare goods and 
services, health expenditure based on essential 
character istics of service recipients
OECD/Eurostat/WHO Europe on  
non-monetary health care benefits
Health care system resources 
and measures
Hospital discharges, hospital stays, medical procedures, 
selected preventive measures and consultations
Causes of death Cause of death statistics ICD causes of death
Accidents at work Statistics on accidents at work Non-fatal/fatal accidents at work
Diagnosis-specific morbidity (pilot phase, 
regular data collection possibly from 2020)
Incidence and prevalence of 
diseases
Diseases (list currently under development)
* planned future implementation under the Framework regulation for the production of European statistics – Integrated European Social Statistics, IESS [30]
OECD=Organisation for Economic Co-operation and Development; Eurostat=Statistical office of the European Union; WHO=World Health Organisation; ICD=International classi-
fication of diseases
data sources and data owners. Among these are the 
EU's statistical office (Eurostat), the World Health 
Organisation’s European ‘Health for all’ database 
(HFA-DB) [31], the database of the Organisation for 
Economic Co-operation and Development (OECD) [32] 
as well as international reporting systems for specific 
issues, for example on tobacco, alcohol and drug con-
sumption, accidents or environmental monitoring. The 
types of data include official statistics, interview and 
administrative data. Eurostat for example provides 
demographic data, population projections, data on 
mortality, life expectancy, fertility, migration and citi-
zenship based on official statistics for all EU member 
states. The European Union Labour Force Survey (EU 
LFS), conducted by all EU member states, two EU can-
didate countries and three countries of the European 
Free Trade Association, provides important data on the 
labour market and employment.
Important survey data for health indicators at Euro-
pean level stems from the European Survey on Income 
and Living Conditions (EU-SILC) and from the European 
Health Interview Survey (EHIS). One quarter of imple-
mented ECHI indicators is collected in the context of EHIS 
[33]. 
Table 1 
Data sets for European health statistics 
Source: [27, 29]
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3.1  European Survey on Income and Living Conditions 
(EU-SILC)
EU-SILC is the EU’s source of reference for comparable 
statistical data on income distribution and social inclu-
sion at European level. The survey provides two types of 
data on an annual basis for the 28 EU members, Iceland, 
Norway, Switzerland and Turkey:
  Cross-sectional data at a particular moment or time-
span on income, poverty, social exclusion and further 
living conditions;
  Longitudinal data on changes over time at individual 
level, periodically surveyed during a specific period, 
usually four years.
The fundament of EU-SILC is a shared “common frame-
work” and not a unitary questionnaire or joint data collec-
tion. This framework consists of a harmonised list of pri-
mary (annual) and secondary (collected at least every four 
years) target variables, which countries commit to trans-
mitting to Eurostat. It also contains overarching guidelines 
and procedures, shared concepts (household and income) 
and classifications to ensure the greatest possible com-
parability of the data provided [34]. EU-SILC was initially 
implemented throughout Europe with framework regula-
tion (EC) 1177/2003 in 2005. In the 2014 wave, the sample 
in Germany covered 12,744 households and 22,695 peo-
ple aged at least 16.
The overarching goal and primary purpose of EU-SILC 
is to provide European and national level social policy with 
a well-grounded basis for decisions. EU-SILC provides the 
basis for monetary and non-monetary social indicators. 
An important social indicator provided by EU-SILC is the 
at-risk-of-poverty rate [35]. Included in EU-SILC is the Min-
imum European Health Module [36], which surveys peo-
ple’s self-perceived health, the presence of chronic dis-
eases and of long-standing limitations in daily activities 
(Global Activity Limitation Indicator, GALI). This module 
is also part of the EHIS. Further health-related surveys 
could in future also use parts of this module. GALI data 
is used to calculate the Healthy Life Years (HLY) indicator 
(also called disability-free life expectancy). In the Lisbon 
Strategy, the indicator belonged to the group of core Euro-
pean structural indicators. Today, HLY is one of two public 
health headline indicators in the EU’s Sustainable Devel-
opment Strategy. EU-SILC also includes questions on why 
people did not go to see a doctor or a dentist, even though 
this would have been medically necessary [35]. 
3.2  European Health Interview Survey (EHIS)
A 2008 EU regulation [37] called on member states to 
supply health statistics in the following domains: health 
status and health determinants, causes of death, health 
care, accidents at work, occupational diseases and oth-
er work-related health problems and illnesses. The Euro-
pean Health Interview Survey (EHIS), which is to be 
conducted every five years, is to serve as the primary 
basis for data on health status and health determinants. 
EHIS is an interview survey which relies on the self-as-
sessment of participants. Unlike in examination surveys, 
no measurements are collected. The first wave of EHIS 
was conducted between 2006 and 2009. Participation 
Since 2013, all EU member 
states are obliged to collect 
health data in the context  
of the European Health  
Interview Survey (EHIS).
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in EHIS 1 was not mandatory and 17 member states took 
part [38]. Germany partly included the EHIS instrument 
in the Robert Koch Institute’s (RKI) German Health 
Update (GEDA 2010) survey and supplied Eurostat with 
results for certain health indicators.
After an intensive process of evaluation of the first wave, 
development of the second and mandatory wave of EHIS 
began. The modules on mental health, physical activity as 
well as on alcohol consumption underwent revision. After 
two further years of work and discussion to develop a bind-
ing catalogue of questions, an EU regulation was adopted 
in February 2013 that defined the EHIS variables, reference 
year and population as well as the required reference meta 
data [39]. 
EHIS consists of four modules on health status (self-as-
sessed), health care, health determinants and background 
demographic and socio-economic status variables. To 
ensure the broadest possible comparability of the data 
received from member states, Eurostat also developed a 
detailed manual, which also includes a model question-
naire [40]. The German language questionnaire is provided 
as a supplement to this edition. Data should be collected 
during the reference years 2013, 2014 or 2015. In Germany, 
EHIS 2 was integrated into GEDA 2014/2015. Beyond the 
EHIS questions, this survey asked further nationally rele-
vant questions to continue earlier time series and/or col-
lect information on specific public health aspects.
The EU regulation on EHIS lists all the variables for the 
survey including the answer categories. Countries freely 
choose their method of data collection and define the 
details of how the survey is conducted. EHIS can be con-
ducted as a stand-alone survey or EHIS questions can be 
integrated into a national health survey, as was the case 
in Germany. A further article in this edition describes the 
methodology applied in GEDA 2014/15-EHIS. EHIS also 
defines the target population (individuals aged 15 and over 
living in private households residing in the territory of the 
Member State at the time of the data collection) and the 
sample size each country needs to achieve (in total around 
195,000 participants in EU member states). To assist data 
processing and data quality assurance, Eurostat provides 
detailed documents and electronic tools. Eurostat controls 
the microdata received from member countries for plau-
sibility and completeness. Each country is required to fill 
out a detailed quality report based on pre-defined criteria, 
which details information on the methodological approach 
chosen by each country. 
Based on this quality assured data, Eurostat calculates 
indicators, which the office usually stratifies according to 
age, gender and education levels. These are available on 
the Eurostat website [41]. 
4. Chronic diseases as an example of EHIS results
EHIS delivers standardised and periodically collected 
core indicators for health monitoring from all countries 
at European level. EHIS thereby mainly contributes indi-
cators on health status and health determinants for 
which no broad and comparable data basis was so far 
available from the various countries. In addition to the 
European indicator systems (mentioned above) and the 
possibility to access indicators through the Eurostat 
database [41], the indicators will be used by the national 
health reporting systems. In Germany, the Journal of 
11
Journal of Health Monitoring FOCUS
Journal of Health Monitoring 2017 2(1)
Chronic diseases considered in the EHIS 2 survey 
Asthma (allergic asthma included)
Chronic bronchitis, chronic obstructive pulmonary disease, 
emphysema
Myocardial infarction or chronic consequences of myocardial 
infarction
Coronary heart disease or angina pectoris
Hypertension
Stroke or chronic consequences of stroke
Arthrosis (arthritis excluded)
Low back pain or other chronic back symptoms
Neck pain or other chronic neck symptoms
Diabetes
Allergy, such as rhinitis, hay fever, eye inflammation, dermatitis, 
food allergy or other (allergic asthma excluded)
Cirrhosis of the liver
Urinary incontinence, bladder control problems
Chronic kidney disease or renal failure
Depression
Health Monitoring publishes Fact sheets on specific indi-
cators and updates these over time taking into account 
newly collected data. The Fact sheets in this issue dis-
cuss indicators for selected chronic diseases with par-
ticular public health relevance: coronary heart disease, 
stroke, hypertension, diabetes and allergies. Future issue 
of the Journal of Health Monitoring will focus on further 
indicators such as arthrosis, asthma and other chronic 
lower respiratory infections (chronic bronchitis, chronic 
obstructive pulmonary disease and emphysema), which 
are presented in brief below.
Overall, EHIS collected information on the occurrence 
of fifteen frequent chronic diseases and health conditions 
through the following question: ‘During the past 12 months, 
have you had any of the following diseases or conditions?’ 
Very clearly, therefore, the survey asked for self-perceived 
illnesses and not self-reported medical diagnoses, diag-
nostic criteria based on objective measurements or other 
disease-specific information such as taking certain med-
ications. 12 months was chosen as a reference period 
because from a health policy point of view information on 
the current prevalence of a disease in the population is of 
higher value than its lifetime prevalence. Moreover, this 
establishes a direct reference to ECHI indicators 21a 
(self-reported diabetes), 23a (self-reported depression), 
26a (self-reported asthma), 27a (self-reported COPD) and 
43 (self-reported high blood pressure) that are all based 
on twelve-month prevalence. Table 2 shows the fifteen 
diseases considered in the EHIS 2 survey.
There are, however, inherent limitations of international 
comparisons of EHIS indicators, just like with other inter-
national indicator systems. On the one hand, this is due 
to the indicators themselves. On the other hand, in spite 
of all efforts to make data collection comparable, numer-
ous differences between countries exist in life expectancy, 
age structure, the organisation and performance of the 
healthcare system, factors concerning the socio-economic 
context and cultural factors; these have to be taken into 
account when interpreting results [42]. Consequently, sim-
ple benchmarking, e.g. a one-dimensional perspective on 
the ranking of individual indicators, makes little sense, 
even more so since Eurostat so far does not provide 
age-standardised prevalence data. 
Figures 3 and 4 therefore present the prevalence of the 
above-mentioned selected chronic diseases according to 
Table 2 
Chronic diseases EHIS-2 
Source: GEDA 2014/15-EHIS, 
German questionnaire 
(see supplement of the German issue)
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Prevalence (%)
Disease






Coronary heart disease or angina pectoris 
Chronic bronchitis, COPD, 
emphysema (except asthma) 
Myocardial infarction or chronic 
consequences of a myocardial infarction
Stroke or chronic consequences of stroke 
Lowest to highest value EU-28 Germany
 
COPD=Chronic obstructive pulmonary disease
Prevalence (%)
Disease






Coronary heart disease or angina pectoris 
Germany
Chronic bronchitis, COPD, 
emphysema (except asthma) 
Myocardial infarction or chronic 
consequences of a myocardial infarction
Stroke or chronic consequences of stroke 
0      5       10           15              20  25     30        35           40  
COPD=Chronic obstructive pulmonary disease
Fig. 3 
12-month prevalence of selected diseases 
among women in Germany compared 
to the EU-28 mean 
Source: EHIS 2014/15 
Fig. 4 
12-month prevalence of selected diseases 
among men in Germany compared 
to the EU-28 mean 
Source: EHIS 2014/15
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Prevalence (%)
Age (years)
 –  –  – 
Germany
 Arthrosis Hypertension Allergies
 –  –  –  –  –  – 
 –  –  – 
 






12-month prevalence of arthrosis, 
hypertension and allergies among women, 
Germany and EU-28 according to age 
Source: EHIS 2014/15 
Fig. 6 
12-month prevalence of arthrosis, 
hypertension and allergies among men, 
Germany and EU-28 according to age 
Source: EHIS 2014/15 
gender in Germany in comparison with the EU average 
including the range between the lowest and highest 
reported values. This analysis did not include indicators 
referring to symptoms, to low-prevalence conditions or to 
mental health.
Whilst prevalence of individual diseases varies consid-
erably across the EU, patterns in women and men are 
quite similar. Country-specific prevalences of asthma and 
other chronic lower respiratory infections, myocardial 
infarction, stroke, coronary heart disease and diabetes vary 
by less than ten absolute percentage points. Variation in 
prevalence is much higher in hypertension (20% in women, 
17% in men), arthrosis (29% in women, 15% in men) and 
allergies (35% in women, 25% in men).
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Figures 5 and 6 focus on the three chronic diseases 
with the largest cross-country differences and show preva-
lences according to age and gender for Germany com-
pared to the EU average. The results confirm for all three 
diseases that prevalences are high in Germany as reported 
from various previous health surveys [43-46]. For both 
genders, the estimated prevalence of arthrosis and hyper-
tension in Germany is slightly higher than the EU average 
and considerably higher for allergies. Also in line with ear-
lier data from Germany, a clear correlation was found 
between age and prevalence of these diseases. A consist-
ent age-related increase in the prevalence of arthrosis and 
hypertension, and an age-related decrease in the preva-
lence of allergies were found for women and men [43-46]. 
The Fact sheets on allergies and hypertension in this issue 
also point to this fact. 
Prevalence of arthrosis
In Germany slightly more respondents reported suffer-
ing from arthrosis than the EU average across all age 
groups. The range of prevalence rates among men was 
between 1.8% and 17.1% (10.1% across the EU, 12.8% 
in Germany), and between 2.7% and 31.8% among wom-
en (18.0% across the EU, 20.9% in Germany). Globally, 
arthrosis is the most common disease of the joints and 
mainly affects people in the second half of life.  The per-
centage of those affected increases with age, and wom-
en are affected more frequently than men [47]. In con-
trast to diseases with early detection programs  like 
diabetes (medical check-up examinations measuring 
glucose levels), arthrosis is usually not detected until 
joints (frequently the hips, knees, arms and hands, shoul-
ders, ankles or feet) are affected. Only medical special-
ists using imaging techniques can explain to what degree 
these symptoms are related to joint degeneration. Both 
people’s perception of joint problems and also their diag-
nosis differ between countries [48, 49]. Moreover, when 
asked about arthrosis, people will often include all kinds 
of problems with their joints, without having a physi-
cian-diagnosed arthrosis. Obesity, joint injuries at a 
younger age and hard physical work are considered 
important risk factors for arthrosis and these factors are 
spread unevenly in the EU. Individually and in combina-
tion, these factors contribute to the differences in prev-
alence.
Prevalence of hypertension
Large differences in the prevalence of hypertension 
across Europe have also been reported previously from 
examination surveys [50]. Since not only the prevalence 
of hypertension, but also people’s awareness of hyper-
tension, varies between European countries, the differ-
ences in prevalence within the EU revealed by the EHIS 
indicator ‘self-reported hypertension in the past 12 
months’ are hardly surprising. For men, prevalences 
range between 12.9% and 29.4% (EU-wide 20.2%, Ger-
many 29.2%) and for women between 14.9% and 34.2% 
(EU-wide 21.7%, Germany 27.8%). As other analyses 
have shown, the higher prevalence of self-reported hyper-
tension among women is due almost entirely to their 
greater awareness of hypertension. When diagnosed in 
examination surveys, however, which also account for 
undetected cases of hypertension, the prevalence of the 
condition is higher among men in most populations [51]. 
Great differences in  
prevalence of arthrosis,  
high blood pressure and 
allergies can be observed  
in Europe.
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as well as of specific immunotherapy (desensitisation), 
vary between countries [53]. 
5. Discussion and outlook
Chronic diseases are among the great challenges for which 
not only the EU member states have to prepare. Interna-
tional and European comparisons on the basis of shared 
indicators can broaden the perspective of national health 
reporting and reveal the need for (health) policy action. 
They can also provide a basis for EU member states to 
share their experiences. Still, methodological and struc-
tural constraints need to be considered which hamper 
European and international comparisons. To illustrate, 
Eurostat, WHO or OECD data, which is used in interna-
tional comparisons, or data from specific surveys may 
vary from the data used at national level for the same mat-
ter. Moreover, national reports may show different values 
than international reports for certain indicators (such as 
the mortality rate) if data has been standardised for age 
for an international comparison. Different statistical pro-
cedures can also lead to differences between national and 
international results. As concerns the ECHI, remarks on 
comparability have been developed for those indicators 
which are not based on EHIS data, but for which data 
from other international sources is available. They explain 
the factors that need to be taken into account in cross-coun-
try comparisons or that have led to the interruption of 
time series in data collection. In addition, contextual fac-
tors have to be considered in the interpretation of com-
parisons between countries and regions. These include 
the heterogeneity of healthcare systems in Europe, the 
Data analysis must take  
into account the differences 




Health monitoring and health indicators in Europe
EHIS prevalences of self-reported hypertension in some 
countries are slightly lower, in other countries consider-
ably lower than prevalence of known hypertension report-
ed from country-specific examination surveys [50]. One 
reason could be that EHIS questionnaires do not grant 
that participants who take medicines and whose hyper-
tension is therefore controlled identify themselves as 
having hypertension. This point should be discussed in 
a review and further development of EHIS indicators. 
For the corresponding indicator in the ECHI shortlist 
(indicator 43), this point was annotated to be considered 
during a later review [11]. 
Prevalence of allergies
With regard to allergies, relatively large differences in 
prevalences between European countries and globally 
have been known for quite some time. The EU average 
for allergy prevalence based on self-reports is 16.9%. The 
EU-wide range of allergy prevalences varies from 1.4% 
to 31.6%. In Germany, the prevalence is 29.0%. On the 
one hand, the large range could express that the risk for 
allergies increases the more sterile an environment is in 
which a person grows up and the fewer a person’s 
immune system has opportunities to deal with patho-
gens and allergens (Hygiene hypothesis [52]). Cross-sec-
tional studies have revealed that children who grow up 
on farms are less likely to develop allergies. On the oth-
er hand, the indicator allergy probably covers a number 
of diseases, presumably also pseudo allergies with a 
broad spectrum of symptoms and degrees of severity 
such as food intolerances. The degree of awareness and 
practical applicability of allergy diagnoses and testing, 
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differences in the availability of relevant data (information 
inequality) as well as cultural differences in understanding 
and dealing with health and illness. The critical appraisal 
of the EHIS data presented here exemplifies this fact.
Numerous projects at European level promote the fur-
ther development of social and health indicators, aiming 
to improve the availability and comparability of data. To 
illustrate, so far, social statistics surveys in Europe were 
implemented on the basis of separate regulations. In the 
context of modernising European social statistics, they 
shall become integrated into the single framework of the 
Integrated European Social Statistics (IESS) regulation. 
This is to ensure that there is a stable data basis to 
strengthen the EU’s social goals. The process began in 
2014, aims for adoption between 2017 and 2018, and 
implementation in 2019.
In the same vein, namely to provide better and com-
parable information on the health of Europeans which 
would allow the EU to evidence-base its health policy activ-
ities, plans are progressing towards the establishment of 
a European Health Information System. The preferred 
structure is that of a European Research Infrastructure 
Consortium on Health Information for Research and Evi-
dence-based Policy (HIREP-ERIC). An ERIC is an interna-
tional institution borne by its participating countries and 
is open not only to members of the EU but also to third 
countries and specialised agencies. Significant work to 
this end is done in the EU-funded BRIDGE Health project 
(2015-2017, http://www.bridge-health.eu). The further 
development of ECHI indicators and their increasing 
implementation in the systems of EU member states, EU 
candidate countries as well as the European Free Trade 
Association (EFTA) countries will be among the most 
important activities. A sustainable EU infrastructure for 
health information creates the necessary framework, con-
tinuity over time and platform for exchanges between 
experts. The overarching goal remains to improve the 
availability and comparability of data relevant to health, 
strengthen the evidence basis for policy and promote the 
exchange of knowledge in Europe.
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Corrigendum, page 16
In the original article, in the section ‘Prev-
alence of allergies’ only the prevalence for 
women was reported instead of the overall 
prevalence for women and men. In the 
current version, the sentence has been 
corrected as follows: ‘The EU average for 
allergy prevalence based on self-reports 
is 16.9%. The EU-wide range of allergy 
prevalences varies from 1.4% to 31.6%. In 
Germany, the prevalence is 29.0%.’
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